Sales drive up CogState revenues
Wednesday, 24 August, 2005
Melbourne-based neurodiagnostic specialist CogState (ASX:CGS) has reported revenues of AUD$1.5 million for the financial year ending June 30 2005, nearly three times more than the previous corresponding period, largely through sales to major pharmaceutical companies and research institutions.
The company recorded an increase in sales of its diagnostic product of 434 per cent, up from $192,094 in 2004 to $1 million in 2005.
Cogstate reported a net loss of $2.2 million and at 30 June 2005 had a cash balance of balance of $3.4 million.
Victoria detects H5N1 avian influenza strain
It follows disease confirmation in seabirds in WA, SA, NSW and Qld and the national decision that...
TGA acts on melatonin imports with infringement notices totalling $99K
Laboratory testing of several imported unregistered melatonin products has confirmed them to be...
Scientists search for cystitis pain 'off switch'
By targeting certain pain receptors in the bladder, Australian scientists believe that the...
